Rationale Peripheral neuropathic pain is a chronic condition that may produce plastic changes in several brain regions. The noradrenergic locus coeruleus (LC) is a crucial component of ascending and descending pain pathways, both of which are frequently compromised after nerve injury.
Introduction
The noradrenergic locus coeruleus (LC) is the main nucleus in the pons involved in pain processing, and based on classical studies of acute pain modulation, it also mediates the inhibition of pain. However, the role of the LC in chronic conditions, as is the case in neuropathic pain following nerve injury, remains poorly understood (Brightwell and Taylor 2009; Hayashida et al. 2008; Viisanen and Pertovaara 2007) . The neurons of the LC signal through an elaborate network of ascending and descending projections. Thus, acute noxious stimuli activate the descending noradrenergic pathway, providing an important means to suppress pain at the spinal level through noradrenaline (NA) release (Jones 1991; Pertovaara and Hamalainen 1994) . By contrast, ascending inputs from the LC to cortical areas, such as the prefrontal cortex (PFC), modulate the cortico-thalamic loop that processes the affective component of pain (Jeanmonod et al. 1993) . Accordingly, the LC is thought to be an important element in the sensory and emotional integration of pain. However, the adaptations that may occur at this level in response to persistent noxious inputs characteristic of neuropathic pain are still unclear (Jaggi and Singh 2011) .
alpha-2-Adrenoceptors (alpha2-AR) are found on the cell body and terminals of noradrenergic neurons in the LC, and they exert a tonic inhibitory influence on NA release. Thus, local or systemic administration of alpha2-AR agonists inhibits the firing activity of the LC (Jedema et al. 2008; Svensson et al. 1975) and decreases the extracellular concentration of NA in the PFC (Pudovkina et al. 2001) . Accordingly, intra-LC administration of alpha2-AR antagonists increases the antinociceptive effect of NA in the spinal cord (Xu et al. 2000) . alpha2-AR activity augments in the spinal cord in neuropathy (Chen et al. 2011; Obata et al. 2005; Omiya et al. 2008; Xu et al. 2000) , and thus it has been suggested that nerve injury may induce tonic activation of alpha2-AR in the LC. This tonic activation would in turn promote neuropathic hypersensitivity by attenuating the inhibition mediated by the descending pathway (Brightwell and Taylor 2009; Viisanen and Pertovaara 2007) . However, to date there is no direct experimental evidence to validate this hypothesis.
In the present study we evaluated the activity of the LC in the rat chronic constriction injury (CCI) model of peripheral neuropathic pain and that of its main afferents: the paragigantocellularis nucleus (PGi) and dorsal raphe nucleus (DRN). Analyses were performed 7 days after injury, when pain hypersensitivity is already evident. Given that the alpha2-AR are fundamental components of the noradrenergic system, we focused on their contribution to these responses and that of their downstream signalling proteins in the LC.
Methods

Subjects and experimental design
Male Sprague-Dawley rats (250-300 g) were housed under standard laboratory conditions in accordance with the guidelines of the European Communities directive 86/609/ EEC and Spanish Laws regulating animal research (RD 1201 (RD /2005 . All experimental protocols were reviewed and approved by the Institutional Ethical Committee for animal care and use at the University of Cadiz. All studies were carried out 7 days after surgery unless otherwise indicated. One set of sham operated and CCI rats were used to establish the nociceptive behaviour index, and independent groups of animals were used for the electrophysiological, microdialysis, immunohistochemistry and western blot assays.
Neuropathic pain model: chronic constriction injury CCI was produced as described previously (Bennett and Xie 1988; Berrocoso et al. 2007 ) after rats were anaesthetized by intraperitoneal (i.p.) injection of a cocktail consisting of 100 mg/kg ketamine and 20 mg/kg xylazine. Briefly, the left sciatic nerve was exposed at the mid-thigh level proximal to the sciatic trifurcation, and four chromic gut (4/0) ligatures were tied loosely around the nerve, 1.0-1.5 mm apart so as not to compromise the vascular supply. Sham operations were performed in the same manner but with no nerve ligation.
Nociceptive behavioural assessment Rats were tested for allodynia and hyperalgesia behaviour at several time points (prior to, 2 days and 7 days after surgery). Mechanical allodynia was measured using an electronic version of von Frey test (Dynamic Plantar Aesthesiometer, Ugo Basile, Italy), whereby a vertical force was applied to the left hind paw increasing from 0 to 50 g over a period of 20 s. The mechanical hyperalgesia was tested by the paw-pinch test (Randall and Selitto 1957) , gradually applying increasing pressure by using a graded motor-driven device (Ugo Basile, Italy). A 250-g cut-off was used to prevent tissue damage. To determine the thermal allodynia (Berrocoso et al. 2007) , the rat was placed on a cold metal plate maintained at 4±1°C (Panlab S.L., Spain), and the number of times the animal briskly lifted its left hind paw over a period of 2 min was measured. To evaluate the thermal hyperalgesia, constant radiant heat (50 A) was generated by a Plantar test device (Ugo Basile, Italy) and applied to the left hind paw with a 30-s cut-off.
Surgery and electrophysiological recordings
Single-unit extracellular recordings of LC neurons (contralateral to the operated hind paw) were obtained 7 days after surgery (Berrocoso et al. 2006) . Animals were anaesthetized with chloral hydrate (400 mg/kg i.p.) and placed in a stereotaxic frame (David Kopf, USA). The recording electrode was lowered into the right LC (relative to lambda: AP −3.7 mm, LM −1.1 mm, DV −8.2: Paxinos and Watson 2009), and the neurons were identified by standard criteria (Cedarbaum and Aghajanian 1976) . Burst firing onset and termination was defined as the concurrence of two spikes with an interspike interval between 0.08 and 0.16 s. Firing patterns were analyzed offline, using the computer software Spike2 (Cambridge Electronic Design, UK), and the basal parameters were calculated. At the end of each experiment, the location of the recording site was verified.
Dose-response curves were constructed for clonidine (alpha2-AR agonist: Sigma Chemical, USA), UK14,304 (bromoxidine, alpha2-AR agonist: Tocris Bioscience, UK), RX821002 (alpha2-AR antagonist: Sigma Chemical, USA) and desipramine (NA reuptake inhibitor: Sigma Chemical, USA). Only one dose-response curve was obtained per rat. In the case of clonidine, UK14,304 and desipramine, the dose-response curves were analyzed for the best non-linear fit to the logistic three-parameter equation (Parker and Waud 1971) : E=E max [A] n /(ED 50 n +[A] n ), where [A] is the intravenous (i.v.) dose of the drug, E is the effect on the firing rate induced by A, and E max is the maximal percentage change at "infinite" dose (100%). ED 50 is the effective dose eliciting 50% of E max , and n is the slope factor of the dose-response curve.
Surgery and microdialysis
Seven days after surgery the animals were anaesthetized with chloral hydrate (400 mg/kg i.p.) and placed in a stereotaxic frame (David Kopf, USA). Two microdialysis probes were implanted in the rat's brain: one in the right LC and the other in the right PFC (Mateo et al. 2001; Paxinos and Watson 2009) . The rats were placed in a CMA/120 microdialysis system (CMA Microdialysis, Sweden) for freely moving animals, and artificial cerebrospinal fluid (aCSF), containing 1 μM desipramine, was perfused through the microdialysis probes at a flow rate of 1 μl/ min. Desipramine was used to increase the NA concentration near the dialysis probe, thus ensuring a sufficient recovery of NA to allow the analysis of the monoamine. Dialysate samples were collected every 35 min, of which the first three samples were used to determine the basal concentrations. In order to preserve NA, 5 μl of HClO 4 (0.1 M) was added to each vial. Clonidine or RX821002 was perfused by reverse dialysis through the LC probe at increasing concentrations. At the end of each experiment, the correct placement of the microdialysis probes was verified.
Chromatography NA concentrations were measured by HPLC coupled to an electrochemical detector. The mobile phase (12 mM citric acid, 1 mM EDTA, 1.2 mM sodium octyl sulphate, 11% methanol) was filtered, degassed and delivered at a flow rate of 0.2 ml/min by a Hewlett-Packard 1100 pump. The stationary phase was a Zorbax Eclipse Plus column (3.5 μ C18, 2.1×150 mm, Agilent Technologies, Spain). NA was measured by amperometric detection at an oxidizing potential of+650 mV.
Immunoprecipitation and western blots
Immunoprecipitation of alpha2-AR from tissues was performed as described previously (Garzon et al. 2005a) . Briefly, the LC were collected 7 days after surgery, homogenized and centrifuged to obtain a crude synaptosomal pellet. About 1 mg of protein in the pellet was solubilized by sonication in a solution containing 50 mM Tris-HCl [pH 7.7], as well as protease and phosphatase inhibitors. The solubilized membranes were incubated with biotin conjugated primary antibodies (affinity-purified IgGs Pierce #21217 and 21339: Fisher Scientific, Spain) raised against the second extracellular loop of the alpha2-AR (KKGAGGGQQPAEPS; GeneScript, USA). The immunoprecipitated proteins were resolved by SDS/polyacrylamide gel electrophoresis (PAGE, 7-14% total acrylamide concentration, 2.6% bisacrylamide cross-linker concentration), and the separated proteins were then transferred to 0.2 μm polyvinylidene difluoride membranes (BioRad 162-0176, Spain). The primary antibodies were detected using the corresponding horseradish peroxidase conjugated secondary antibodies (1:10,000), and antibody binding was visualized with the Immobilon Western Chemiluminescent HRP substrate (Millipore WBKLS0100). Densitometry was expressed as the integrated volume (average optical density of the pixels within the object area/mm 2 ). The following rabbit primary antibodies were used (Garzon et al. 2005a (Garzon et al. , 2005b Rodriguez-Munoz et al. 2007 ): anti-Gαi 2 (against aa 115-125), anti-Gα z (aa 19-31 and 111-125), anti-RGS14 (aa 236-250) and anti-RGSZ2 (aa 192-215) . In addition, anti-RGS11 (ab13725) and anti-β-actin (ab1801) were obtained from Abcam plc (UK), while anti-RGS4 (sc6204), anti-RGS7 (sc8139) and anti-RGS9-2 (sc8142 and sc8143) were purchased from Santa Cruz Biotech (Quimigen S.L., Spain).
Immunohistochemistry
Briefly, rats were perfused with 4% paraformaldehyde 7 days after surgery (Cruz et al. 2005) . For alpha2A-AR and phosphorylated extracellular signal-regulated kinases 1/2 (pERK1/2) immunohistochemistry, free-floating sections (20 and 40 μm thick respectively) were incubated with antibodies against alpha2A-AR (1:50, ab45871: Abcam plc, UK) or pERK1/2 (1:1,000: Neuromics, USA), and with a biotinylated secondary antibody, the binding of which was detected using the ABC kit (Vector Laboratories, UK) and 3,3-diaminobenzidine tetrahydrochloride as the chromogen. For analysis, the histological delimitation of areas of interest was performed according to Paxinos and Watson (2009) . To quantify the alpha2A-AR immunoreactivity in the LC, photomicrographs were captured from all sections containing not only the region of interest but also non-specific labelling (non-specific labelling region-NLR) and of the glass of each slide (glass background labelling region-GBLR). Densitometric analysis of each photomicrograph was performed using free access software (Image J 1.42), and the mean grey densitometric values in each section and for each rat were calculated using the following equation: (LC mean grey−GBLR mean grey)/(NLR mean grey−GBLR mean grey). We also explored the expression of pERK1/2, a marker of neural activation (Ji et al. 2009; Kawasaki et al. 2004; Shimizu et al. 2006) , in distinct areas involved in nociceptive transmission to the LC: the spinal cord, PGi and DRN. To quantify pERK1/2, the number of cell bodies immunolabelled in the dorsal horn of the spinal cord (L4, L5 and L6: Swett and Woolf 1985) was quantified in laminae I-III, IV-VI, VII-IX and X (Cruz et al. 2005; Molander et al. 1984) . The number of pERK1/2 immunoreactive (IR) cells was then divided by the total number of sections obtained from each rat and expressed as the number of pERK1/2 IR cells/section/animal. A similar approach was used to count pERK1/2 IR cells in sections containing the PGi and DRN.
Statistical analysis
All the data are presented as the mean±S.E.M. As no differences were found between the ipsilateral and contralateral sides in immunohistochemical studies of the LC, PGi and DRN, these data were pooled for all analyses. Statistical significance was assessed (Prism 5.0; GraphPad Software, USA) using an unpaired Student'st-test to compare between two groups. Comparisons of more than two groups were performed using one-way or two-way repeated analysis of variance (ANOVA) followed by Bonferroni post-hoc test. Fisher's exact test was used to analyze two categorical variables. The level of significance was considered as p<0.05.
Results
Effect of CCI on behavioural response
Rats exhibited pronounced allodynic and hyperalgesic behaviour 2 and 7 days after CCI induction, reflecting the neuropathic pain in this model of nerve injury. The nociceptive threshold of these animals in response to von Frey filament stimulation, paw pressure and radiant heat was significantly lower than that of sham animals (p< 0.001; p<0.001 and p<0.001 respectively, Bonferroni posthoc test: Fig. 1a, c, d ). In the cold-plate test of CCI, rats lifted their paws more frequently (p<0.001, Bonferroni post-hoc test: Fig. 1b ) while as expected cold allodynia was not observed in sham operated animals (average paw lifts: 1.7±0.4 per test).
Effect of CCI on the electrophysiological activity of the LC Basal tonic activity in sham animals was similar to that previously described in studies of LC activity in anaesthetized rats (Berrocoso et al. 2006) . When compared to the sham operated group, experimental neuropathy did not modify the spontaneous firing characteristics of LC neurons contralateral to the operated paw, their mean basal firing rate or regular firing pattern (variation coefficient), or their burst firing (p>0.05, Student'st-test: Table 1 ).
Several assays were performed to assess alpha2-AR function. Firstly, when the firing discharge of one LC neuron was stabilized, i.v. administration of the alpha2-AR agonists UK14,304 (2.5, 5, 10, 20, 40 and 80 μg/kg) or clonidine (0.3, 0.6, 1.2, 1.8, 2.5, 3.7, 5, 10 and 20 μg/kg) inhibited spontaneous activity in a dose-dependent manner (Fig. 2a, d ). In nerve-injured rats the ED 50 of UK14,304 was not significantly changed when compared to sham animals (p>0.05, Student'st-test: Fig. 2b, c) . However, in CCI rats clonidine-induced inhibition was attenuated (Fig. 2c, f) , shifting the dose-response curves to the right and significantly increasing the ED 50 value of clonidine (p<0.001, Student'st-test: Table 1 ). Clonidine and UK14,304 completely inhibited the spontaneous activity of LC neurons (E max = 100%), an effect that was reversed by i.v. administration of the alpha2-AR antagonist idazoxan (100 μg/kg: Fig. 2a, b, d, e) .
Intravenous administration of the NA reuptake inhibitor desipramine (0.05, 0.1, 0.2, 0.4, 0.8 and 1.6 mg/kg) inhibited basal activity of LC neurons in a dose-dependent manner (Fig. 2g) . No differences in the ED 50 were observed between CCI and sham rats (p>0.05, Student'st-test: Fig. 2h, i) . Desipramine completely inhibited the activity of LC neurons (E max =100%), an effect that was reversed up to 30% by i.v. administration of idazoxan (100 μg/kg: Fig. 2g, h ). By contrast, intravenous administration of the alpha2-AR antagonist RX821002 (0.13, 0.25, 0.5, 1.0 and 2.0 mg/kg) increased the LC firing rate in a dose-dependent manner (Fig. 2j) , although no differences were observed between CCI and sham rats (p>0.05, Student'st-test: Fig. 2k, l) . The maximal excitatory effect recorded was very similar between both groups (sham: 39.3±3.4%; CCI: 45.0±6.0%).
Effect of CCI on extracellular NA concentrations in the LC and PFC Seven days after CCI, basal extracellular NA levels were measured in the LC and PFC. When the NA levels were compared in each area, there were no differences between sham and neuropathic rats (p>0.05, Student'st-test: Table 1) , and in both regions the NA concentrations were within the range described for healthy rats (Ortega et al. 2010 ).
To evaluate alpha2-AR function in the LC, clonidine or RX821002 was administered locally to the LC via reverse dialysis, and the NA concentration was measured in both the LC and PFC. The administration of clonidine to the LC (0.1, 1, 10 and 100 μM) decreased the extracellular NA levels in this nucleus in a concentration-dependent manner (Fig. 3a) , with a maximal inhibitory effect of 39.0±15.0%, as seen elsewhere (Mateo et al. 2001 ). In the same rats, the administration of clonidine to the LC induced a significant decrease in NA in the PFC (Fig. 3c) , with a maximal inhibitory effect of 50.0±9.0%. Local administration of RX821002 (0.1, 1, 10 and 100 μM) into the LC evoked a Fig. 2 Effect of CCI on the LC alpha2-AR activity measured by in vivo electrophysiology. Representative examples of firing rate recordings from LC neurons showing the dose-dependent effect of UK14,304 (a, b), clonidine (d, e), desipramine (g, h) and RX821002 (j, k) in sham and CCI rats 7 days after surgery (scale bar=1 min). Drugs were administered i.v. at increasing doses (arrows). Note that the dose-dependent inhibitory effect of UK14,304, clonidine and desipramine were reversed by the subsequent i.v. administration of idazoxan (IDX). Dose-response curves illustrating the effect of UK14,304 (c), clonidine (f), desipramine (i) and RX821002 (l) on the firing rate of LC neurons in sham and CCI rats. Each symbol represents the mean±S.E.M. of the percentage decrease or increase from the basal firing rate of four-eight neurons. Note that the horizontal axis represents the cumulative drug doses. In c-i the horizontal axis is represented in logarithmic scale, and the theoretical curve in each group was estimated by non-linear regression (see "Methods") concentration-dependent increase in extracellular NA in both LC (maximal effect of 302±72%) and PFC (maximal effect of 170±16%), although no differences were observed between CCI and sham rats (p>0.05, two-way ANOVA: Fig. 3b, d ).
Effect of CCI on the expression of alpha2-AR and related signalling proteins in the LC Different experimental approaches have demonstrated alpha2A-AR to be the predominant alpha-AR subtype in the LC (Holmberg et al. 2003; Scheinin et al. 1994; Talley et al. 1996 ). Thus, we investigated possible changes in alpha2A-AR expression in the LC following CCI. Inducing neuropathy had no effect on alpha2A-AR levels in the membrane when assessed in western blots (p>0.05, Student's t-test: Fig. 4) . Accordingly, no changes in alpha2A-AR immunoreactivity were observed in sequential brain sections (p > 0.05, Student's t-test: Fig. 5 ). alpha2-AR is a G-protein coupled receptor that transduces its biological signals through heterotrimeric GTP-binding Quantification of the data from the contralateral and ipsilateral LC of sham operated and CCI rats, where immunosignals were expressed as the change relative to sham animals (attributed an arbitrary value of 1, white column). Each column represents the mean of three assays performed on LC samples obtained from independent groups of six to seven animals proteins (Gαi/z proteins) (Gilsbach and Hein 2008) , a transduction pathway that is modulated by regulators of G-protein signalling (RGS) (Hollinger and Hepler 2002) . No effect of CCI was observed on the levels of Gαi/z proteins or on a range of their associated RGS proteins in western blots (RGS4, 7, 11, 14, 9-2 and Z1; p>0.05, Student'st-test: Fig. 4 ).
Effect of CCI on LC afferents: pERK1/2 expression
We explored the expression of pERK1/2, an activated form of ERK, in areas involved in the transmission of nociceptive information to the LC: the spinal cord, PGi and DRN (Fig. 6) . The expression of pERK1/2 was identified by the accumulation of a brown precipitate, and in agreement with previous data (Tseng et al. 2007; Van Steenwinckel et al. 2011) , CCI significantly increased the number of cells expressing pERK1/2 in the spinal cord ipsilateral to the injury (p<0.05, Student'st-test: Fig. 6a-c) . The pERK1/2 expressing cells were distributed mainly in laminae I and II, consistent with the activation of the spinoreticular tract (Renn and Dorsey 2005) . A few labelled neurons were also distributed in other laminae or in the contralateral domain. In the midbrain, these neurons connect with distinct areas, such as the PGi, the rostral ventromedial medulla (RVM) and the DRN. Indeed, CCI also induced a significant increase in the number of pERK1/2 immunoreactive cells in the PGi (p<0.01 Student'st-test: Fig. 6d-f) and DRN (p<0.05, Student'st-test: Fig. 6g-i) .
Discussion
The present study demonstrates that the basal electrical activity of LC neurons is preserved in the rat CCI model of peripheral neuropathic pain 7 days after surgery. alpha2-AR activity, which controls the firing of LC noradrenergic neurons, was also unaltered, as was NA release in the somatodendritic and terminal areas (such as the PFC). Furthermore, no changes were observed in the expression of downstream proteins that transduce the signals from the alpha2-AR and that mediate the intracellular responses to receptor activation. By contrast, an increase in pERK1/2 expression was found in LC afferents in neuropathic animals, such as the PGi and DRN.
Several studies have demonstrated that acute pain (tail pinch, footshock, heat) enhances the firing rate of LC neurons (Aston-Jones and Bloom 1981; Cedarbaum and Aghajanian 1978; Elam et al. 1986; Hajos et al. 1986) , as well as the turnover and metabolism of NA (Korf et al. 1973; Singewald and Philippu 1998) . To date, few comparable studies of chronic pain have been carried out, even though the increase in ascending nociceptive inputs after nerve injury (Chapman et al. 1998; Pertovaara et al. 1997) suggests that enhanced neuronal activity in the LC is probable in these experimental conditions. Surprisingly, we found no changes in the spontaneous electrophysiological activity of LC neurons in CCI animals that exhibit allodynia and hyperalgesia, in agreement with findings in a spinal nerve ligation model of neuropathy (Viisanen and Pertovaara 2007) . This absence of basal electrical changes may reflect the increase in the auto-inhibitory activity of alpha2-AR, which could be explained by two possible mechanisms. The first would be an increase in extracellular NA in the LC in the absence of modified alpha2-AR expression. This increased availability of endogenous NA in the LC milieu would lead to the over-activation of alpha2-AR, although this hypothesis is contradicted by our failure to detect a change in basal NA levels in the LC 7 days after the induction of experimental neuropathy. The second possibility is that alpha2-AR activity is enhanced in the absence of changes in NA levels. However, this hypothesis is not consistent with our studies of alpha2-AR function, where 7 days after surgery there were no changes in the response to the alpha2-AR agonist, UK14,304 (bromoxidine), or the antagonist, RX821002. In the presence of the NA reuptake blocker desipramine, alpha2-AR were activated by increasing concentrations of endogenous NA, attenuating the firing of LC neurons (West et al. 2009) . No differences in this activity were observed between CCI rats and sham operated animals, and indeed the blockage of alpha2-AR with the highly selective antagonist RX821002 again revealed no differences between CCI and the control animals. By contrast, the use of clonidine produced paradoxical results, since systemic administration of clonidine shifted the dose-response curve to the right and increased the ED 50 values in neuropathic rats when compared to sham operated controls. However, in microdialysis studies the administration of clonidine to the LC exerted similar effects both in CCI and sham operated animals. Thus, the reduced potency of clonidine after i.v. administration may be due to its action at non-adrenergic binding sites expressed outside the LC, known as Iimidazoline receptors, such as those in the PGi (Ernsberger et al. 1995; Parini et al. 1996; Ernsberger and Shen 1997; Meana et al. 1997; Martin-Gomez et al. 2005) . Indeed, local administration of clonidine to the PGi increases the firing rate in the LC when alpha2-AR are blocked, again presumably through their action on I 1 -imidazoline receptors in the PGi (Pineda et al. 1993; Ruiz-Ortega et al. 1995; Ruiz-Ortega and Ugedo 1997) . Thus, the apparent attenuation of i.v. clonidine response in conditions of neuropathic pain is probably due to hypersensitization of I-imidazoline receptors located outside the LC. Moreover, i.v. administration of UK14,304 in sham and CCI rats has a similar effect on spontaneous LC neuron activity. This is probably due to its low affinity for I-imidazoline receptors when compared to alpha2-AR, as demonstrated in binding and functional studies (Bricca et al. 1993; Georges and Aston-Jones 2003; Georges et al. 2005; Urban et al. 1995) . Interestingly, I-imidazoline agonists, mainly of subtype 2, promote the antinociceptive effects of morphine inputs enter the spinal dorsal horn through primary afferents (sciatic nerve), and through the spinothalamic tract, the projection fibers ascend contralaterally to brainstem nuclei, such as the PGi (in the medulla oblongata) and DRN (in the midbrain). The DRN also receives afferents from the nucleus raphe magnus and thalamus. The LC receives stronger excitatory and inhibitory inputs from both the PGi and DRN, respectively, resulting in a null effect on the LC tonic activity in the CCI (4 V, 4th ventricle; solid lines, direct projections; dotted line, indirect projections) (Sanchez-Blazquez et al. 2000) , and they provide effective analgesia in animal models of inflammatory and neuropathic pain (Ferrari et al. 2011; Li and Zhang 2011) . Thus, further studies with selective ligands for I 1 -imidazoline or I 2 -imidazoline receptors that are devoid of alpha2-AR activity will be necessary to test this putative higher sensitivity of Iimidazoline receptors in neuropathic pain.
Following CCI, no changes in alpha2-AR expression were evident by immunohistochemistry or in western blots, and no changes in associated signalling pathways were observed in Gαi/αz and RGS (RGS4, 7, 11, 14, 9-2 and Z1) (Gilsbach and Hein 2008) . However, changes in the protein or mRNA expression of some RGS protein subtypes in other brain regions cannot be ruled out. In addition to their role as activators of GTPases acting on Gα subunits, RGS proteins may also modulate signalling pathways via protein-protein interactions, for example acting as scaffolds (Garzon et al. 2005a, b) . Thus, further studies will be necessary to provide a clear picture of the role of RGS proteins in modulating neuropathic pain in vivo.
Our findings provide evidence that normal alpha2-AR function is maintained in conditions of neuropathic pain, exerting a tonic inhibitory effect on noradrenergic activity while controlling NA release in the LC and its terminal areas. Indeed, local administration of the alpha2-AR agonist clonidine in the LC decreases NA release in both the LC and PFC (projection area) to a similar extent in CCI and sham animals. These findings suggest that there is a physiological mechanism that may be pharmacologically modulated to produce pain relief. As such, blockage of alpha2-AR in the LC, as demonstrated with RX821002, may increase the availability of endogenous NA in terminal areas like the spinal cord, enhancing pain relief. Alternatively, alpha2-AR desensitization in LC neurons may contribute to the analgesic effects of antidepressants, exerting noradrenergic effects in conditions of neuropathic pain. We propose that pharmacological blockade of alpha2-AR in the LC will enhance the activity of the descending noradrenergic pathway, contributing to neuropathic pain relief.
As no changes of spontaneous neural activity were found in the LC following CCI, it is plausible to think that the sum of the different signals to the LC amounts to zero (Fig. 6j) . Our results show that neuropathic pain increases pERK1/2 expression in the PGi, the main glutamatergic afferent to the LC in the RVM. Indeed, LC-projecting PGi cells are strongly activated by noxious stimulation of the foot pad and sciatic nerve (Aston- Jones et al. 1986; 1991b; Azami et al. 1981; Ennis et al. 1992; Van Bockstaele et al. 1998) . By contrast, the LC is under the inhibitory control of the serotoninergic DRN (Kim et al. 2004) , which is involved in pain modulation through its connections with the spinal cord, nucleus raphe magnus and thalamus (Basbaum and Fields 1984; Dong et al. 1991; Wang and Nakai 1994) . Moreover, serotonin attenuates the responses of the LC evoked by sensory stimuli (Segal 1979 ) and the glutamate-induced excitation of this nucleus (Aston- Jones et al. 1991a) , suggesting a link between the PGi and DRN in modulating pain. Interestingly, CCI caused serotoninergic hyperactivity, as evident through the increased basal activity of serotoninergic neurons, extracellular serotonin levels and 5-HT1A receptor gene expression (Palazzo et al. 2006) , as well as the increase in pERK1/2 expression observed here. Thus, although other areas of the nervous system may also be involved, we propose that the excitatory input from the PGi is blocked by the inhibition from the DRN, maintaining the tonic LC activity constant in neuropathic pain.
Finally, it would be interesting to know if this compensation at the LC level is maintained over time, because an increase in the number of tyrosine-hydroxylase immunoreactive neurons in the LC has been described 2 weeks after CCI (Ma and Eisenach 2003) , as well as an increase in 14 C-2-deoxyglucose metabolic activity in the LC after 10 days (Mao et al. 1993) . Importantly, our study focuses on the tonic activity of LC neurons, and thus further studies into sensory-evoked conditions in neuropathic animals should be performed. For example, an increased response of LC neurons to noxious somatic stimulation was recently reported 10-14 days after injury (Viisanen and Pertovaara 2007) , and CREB (cAMP response element-binding) expression increased in the LC after nociceptive stimulation of animals experiencing neuropathic pain (Brightwell and Taylor 2009 ). These studies suggest that chronic pain does not modify the tonic activity of the LC but rather that it increases its responsiveness to nociceptive inputs under conditions of neuropathic pain.
In summary, our findings suggest that the allodynia and hyperalgesia observed in nerve-injured animals are not accompanied by modifications in tonic activity or alpha2-AR function in the LC nucleus, reflecting balanced changes in the areas that modulate the activity of this nucleus. Therefore, LC alpha2-autoreceptors apparently continue to exert tonic inhibition of noradrenergic activity in conditions of neuropathic pain.
